The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.
Study highlights a fourfold increase in ME/CFS risk among COVID-19 patients, with 89% of post-COVID ME/CFS cases overlapping ...
Coronavirus can spread easily and cause serious illness in some people, as can other respiratory infections such as flu ...
Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...
Zofin is under clinical development by ZEO ScientifiX and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.
Analysis included two control groups: Strict control group (LRTD events negative for RSV, human metapneumovirus, severe acute respiratory syndrome coronavirus 2, and influenza but positive for ...
Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.
The U.S. Department of Health and Human Services (HHS) formally debarred Peter Daszak, president of EcoHealth Alliance, a ...
“Newcastle disease is not like severe acute respiratory syndrome. It has been endemic for years and doesn’t affect bird’s nest,” said Mr Tan. “Although chickens and swallows are both ...
It started as a respiratory illness – or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...
Mesenchymal Stem Cells-Derived Exosomes is under clinical development by AbelZeta and currently in Phase II for Acute Respiratory Distress Syndrome.